Literature DB >> 22968065

Surgeon knowledge contributes to the relationship between surgeon volume and patient outcomes in rectal cancer.

Devon P Richardson1, Geoff A Porter, Paul M Johnson.   

Abstract

OBJECTIVE: To determine whether surgeon knowledge contributes to the relationship between surgeon procedure volume and patient outcomes in rectal cancer.
BACKGROUND: Although previous research has shown that treatment by high-volume surgeons is associated with improved outcomes among patients with rectal cancer, the mechanisms for such an association are not well understood.
METHODS: In 2009, a mail survey with 8 questions pertaining to rectal cancer care was created, modified for content validity, and sent to all general surgeons in Nova Scotia, Canada. Patients with rectal cancer, who were treated by the survey respondents between July 1, 2002, and June 30, 2006, were identified retrospectively, and a comprehensive standardized review of medical records was used to collect outcome data for this population-based cohort. The association between surgeon survey score (dichotomized into high- and low-score groups on the basis of the median score), surgeon procedure volume, and patient outcomes was examined.
RESULTS: Of 521 patients who underwent treatment with curative intent from July 1, 2002, to June 30, 2006, 377 patients (72%) were treated by 25 surgeons who responded to the survey. After controlling for patient and tumor factors, patients treated by high-volume surgeons were more likely to receive a total mesorectal excision (TME) [odds ratio (OR) = 3.89; 95% confidence interval (CI), 2.20-5.83], more likely to undergo an adequate lymph node harvest (OR = 3.67; 95%CI, 2.36-5.70), less likely to have a permanent colostomy (OR = 0.53; 95%CI, 0.30-0.93), and less likely to develop local recurrence (HR = 0.54; 95%CI, 0.29-0.99). When surgeon survey score was included in the multivariate regression models, the relationship between surgeon procedure volume and permanent colostomy was diminished. There was a significant interaction between surgeon survey score and surgeon volume for the outcomes of use of TME (P < 0.01) and local recurrence (P = 0.01).
CONCLUSIONS: These data suggest that surgeon knowledge may, at least in part, explain surgeon volume-associated differences in rectal cancer outcomes.

Entities:  

Mesh:

Year:  2013        PMID: 22968065     DOI: 10.1097/SLA.0b013e31825ffdca

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  11 in total

1.  Systematic review and a meta-analysis of hospital and surgeon volume/outcome relationships in colorectal cancer surgery.

Authors:  Ya Ruth Huo; Kevin Phan; David L Morris; Winston Liauw
Journal:  J Gastrointest Oncol       Date:  2017-06

2.  A Comparison of Pathologic Outcomes of Open, Laparoscopic, and Robotic Resections for Rectal Cancer Using the ACS-NSQIP Proctectomy-Targeted Database: a Propensity Score Analysis.

Authors:  Richard Garfinkle; Maria Abou-Khalil; Sahir Bhatnagar; Nathalie Wong-Chong; Laurent Azoulay; Nancy Morin; Carol-Ann Vasilevsky; Marylise Boutros
Journal:  J Gastrointest Surg       Date:  2018-09-27       Impact factor: 3.452

3.  Development of The American Society of Colon and Rectal Surgeons' Rectal Cancer Surgery Checklist.

Authors:  Sean C Glasgow; Arden M Morris; Nancy N Baxter; James W Fleshman; Karim S Alavi; Martin A Luchtefeld; John R T Monson; George J Chang; Larissa K Temple
Journal:  Dis Colon Rectum       Date:  2016-07       Impact factor: 4.585

Review 4.  Surgery for rectal cancer-what is on the horizon?

Authors:  Thomas A Vermeer; Ricardo G Orsini; Harm J T Rutten
Journal:  Curr Oncol Rep       Date:  2014-03       Impact factor: 5.075

5.  Self-reported practice patterns and knowledge of rectal cancer care among Canadian general surgeons.

Authors:  Devon P Richardson; Geoff A Porter; Paul M Johnson
Journal:  Can J Surg       Date:  2014-12       Impact factor: 2.089

6.  Colon cancer lymph node evaluation among military health system beneficiaries: an analysis by race/ethnicity.

Authors:  Abegail A Gill; Shelia H Zahm; Craig D Shriver; Alexander Stojadinovic; Katherine A McGlynn; Kangmin Zhu
Journal:  Ann Surg Oncol       Date:  2014-07-25       Impact factor: 5.344

7.  Guideline-Recommended Chemoradiation for Patients With Rectal Cancer at Large Hospitals: A Trend in the Right Direction.

Authors:  Natalie J Del Vecchio; Jennifer A Schlichting; Catherine Chioreso; Amanda R Kahl; Jennifer E Hrabe; Charles F Lynch; Michele M West; Mary E Charlton
Journal:  Dis Colon Rectum       Date:  2019-10       Impact factor: 4.585

Review 8.  Early detection of colorectal cancer recurrence in patients undergoing surgery with curative intent: current status and challenges.

Authors:  Patrick E Young; Craig M Womeldorph; Eric K Johnson; Justin A Maykel; Bjorn Brucher; Alex Stojadinovic; Itzhak Avital; Aviram Nissan; Scott R Steele
Journal:  J Cancer       Date:  2014-03-15       Impact factor: 4.207

9.  Surgeons' knowledge regarding the diagnosis and management of pancreatic cancer in China: a cross-sectional study.

Authors:  Bing-Qi Li; Li Wang; Jian Li; Li Zhou; Tai-Ping Zhang; Jun-Chao Guo; Yu-Pei Zhao
Journal:  BMC Health Serv Res       Date:  2017-06-09       Impact factor: 2.655

Review 10.  The modern anatomical surgical approach to localised rectal cancer.

Authors:  R G Orsini; T Wiggers; M C DeRuiter; P Quirke; R G Beets-Tan; C J van de Velde; H J T Rutten
Journal:  EJC Suppl       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.